Standardized community management on the diagnosis, treatment, and risk factors control for non-valvular atrial fibrillation in elderly patients

被引:1
作者
Wang, Wei [1 ]
Gu, Yufeng [2 ]
Wei, Shan [1 ]
Xie, Juan [3 ]
Zheng, Xiuli [1 ]
Yu, Yan [4 ]
机构
[1] Zhuanqiao Community Hlth Serv Ctr, Dept Gen practice, Shanghai, Peoples R China
[2] Fifth Peoples Hosp Shanghai, Dept Infect Dis, Shanghai, Peoples R China
[3] Fifth Peoples Hosp Shanghai, Dept Gen practice, Shanghai, Peoples R China
[4] Fifth Peoples Hosp Shanghai, Dept Pharm, Shanghai, Peoples R China
来源
BMC PRIMARY CARE | 2023年 / 24卷 / 01期
关键词
Atrial fibrillation; Elderly; Community hospital; Health management; Risk factors; ORAL ANTICOAGULANTS; HEALTH MANAGEMENT; DIABETES-MELLITUS; HYPERTENSION; WARFARIN;
D O I
10.1186/s12875-023-02207-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background By investigating the knowledge, medication, occurrence of complications, and risks among elderly non-valvular atrial fibrillation (NVAF) patients in Shanghai communities, and providing standardized comprehensive management and follow-up, we aim to explore the impact of standardized community management on improving disease awareness, standardizing atrial fibrillation (AF) treatment, reducing the risk of complications occurrence, and addressing risk factors for AF patients.Methods This research selected elderly atrial fibrillation patients from Zhuanqiao Community Health Service Center, Minhang District, Shanghai from July 2020 to October 2022. Their personal health records and examination results were reviewed, and the incidence of AF, awareness, medication, and complications were investigated. Age-adjusted Charlson Comorbidity Index (aCCI), CHA(2)DS(2)-VASc score, and HAS-BLED score were used to evaluate disease burden, thromboembolic risk, and bleeding risk, respectively. The patients were subjected to standardized community management, and the compliance rate of disease awareness, treatment, resting heart rate, blood pressure, fasting blood glucose, and body mass index (BMI) were assessed at the baseline, 6 months and 1 year after management.Results A total of 243 NVAF patients were included, with an average aCCI score of (4.5 +/- 1.1). Among them, 28% of the patients were aware of their AF, and 18.1% of the patients were aware of the hazards of AF. Of the patients, 11.9% used anticoagulant drugs, including 6.6% and 5.3% for warfarin and non-vitamin K antagonist oral anticoagulants (NOACs), respectively. 7% of patients used antiplatelet drugs. 26.7% of the patients used heart rate control drugs. 10.3% of the patients experienced thromboembolic events, and 0.8% of the patients experienced bleeding events. 93.0% of the patients were at high risk of thromboembolism, and 24.7% of the patients were at high risk of bleeding. Compared with the baseline, there were significant statistical differences (P < 0.001) in disease awareness, awareness of the hazards of AF, use of anticoagulant drugs and heart rate control drugs, and control of risk factors among NVAF patients after standardized community management. Moreover, with the extension of management time, there was a linear increase in the awareness of NVAF, awareness of the hazards of AF, utilization rate of anticoagulant drugs, utilization rate of heart rate control drugs, blood pressure, blood glucose, and BMI compliance rate (P < 0.001).Conclusion Currently, the awareness, treatment, and control of risk factors for AF in elderly NVAF patients in Shanghai community are not satisfactory. Standardized community management helps to improve the diagnosis, treatment, and control of risk factors in AF.
引用
收藏
页数:8
相关论文
共 29 条
  • [21] Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study
    Pallisgaard, Jannik L.
    Schjerning, Anne-Marie
    Lindhardt, Tommi B.
    Procida, Kristina
    Hansen, Morten L.
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (06) : 621 - 627
  • [22] Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
    Roth, Gregory A.
    Mensah, George A.
    Johnson, Catherine O.
    Addolorato, Giovanni
    Ammirati, Enrico
    Baddour, Larry M.
    Barengo, Noel C.
    Beaton, Andrea Z.
    Benjamin, Emelia J.
    Benziger, Catherine P.
    Bonny, Aime
    Brauer, Michael
    Brodmann, Marianne
    Cahill, Thomas J.
    Carapetis, Jonathan
    Catapano, Alberico L.
    Chugh, Sumeet S.
    Cooper, Leslie T.
    Coresh, Josef
    Criqui, Michael
    DeCleene, Nicole
    Eagle, Kim A.
    Emmons-Bell, Sophia
    Feigin, Valery L.
    Fernandez-Sola, Joaquim
    Fowkes, Gerry
    Gakidou, Emmanuela
    Grundy, Scott M.
    He, Feng J.
    Howard, George
    Hu, Frank
    Inker, Lesley
    Karthikeyan, Ganesan
    Kassebaum, Nicholas
    Koroshetz, Walter
    Lavie, Carl
    Lloyd-Jones, Donald
    Lu, Hong S.
    Mirijello, Antonio
    Temesgen, Awoke Misganaw
    Mokdad, Ali
    Moran, Andrew E.
    Muntner, Paul
    Narula, Jagat
    Neal, Bruce
    Ntsekhe, Mpiko
    de Oliveira, Glaucia Moraes
    Otto, Catherine
    Owolabi, Mayowa
    Pratt, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (25) : 2982 - 3021
  • [23] Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
    Ruff, Christian T.
    Giugliano, Robert P.
    Braunwald, Eugene
    Hoffman, Elaine B.
    Deenadayalu, Naveen
    Ezekowitz, Michael D.
    Camm, A. John
    Weitz, Jeffrey I.
    Lewis, Basil S.
    Parkhomenko, Alexander
    Yamashita, Takeshi
    Antman, Elliott M.
    [J]. LANCET, 2014, 383 (9921) : 955 - 962
  • [24] Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
    Schnabel, Renate B.
    Marinelli, Elena Andreassi
    Arbelo, Elena
    Boriani, Giuseppe
    Boveda, Serge
    Buckley, Claire M.
    Camm, A. John
    Casadei, Barbara
    Chua, Winnie
    Dagres, Nikolaos
    de Melis, Mirko
    Desteghe, Lien
    Diederichsen, Soren Zoga
    Duncker, David
    Eckardt, Lars
    Eisert, Christoph
    Engler, Daniel
    Fabritz, Larissa
    Freedman, Ben
    Gillet, Ludovic
    Goette, Andreas
    Guasch, Eduard
    Svendsen, Jesper Hastrup
    Hatem, Stephane N.
    Haeusler, Karl Georg
    Healey, Jeff S.
    Heidbuchel, Hein
    Hindricks, Gerhard
    Hobbs, F. D. Richard
    Huebner, Thomas
    Kotecha, Dipak
    Krekler, Michael
    Leclercq, Christophe
    Lewalter, Thorsten
    Lin, Honghuang
    Linz, Dominik
    Lip, Gregory Y. H.
    Lochen, Maja Lisa
    Lucassen, Wim
    Malaczynska-Rajpold, Katarzyna
    Massberg, Steffen
    Merino, Jose L.
    Meyer, Ralf
    Mont, Lluis
    Myers, Michael C.
    Neubeck, Lis
    Niiranen, Teemu
    Oeff, Michael
    Oldgren, Jonas
    Potpara, Tatjana S.
    [J]. EUROPACE, 2023, 25 (01): : 6 - 27
  • [25] Effects of a nurse-led eHealth cardiac rehabilitation programme on health outcomes of patients with coronary heart disease: A randomised controlled trial
    Su, Jing Jing
    Yu, Doris Sau-Fung
    [J]. INTERNATIONAL JOURNAL OF NURSING STUDIES, 2021, 122
  • [26] Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
    Violi, Francesco
    Soliman, Elsayed Z.
    Pignatelli, Pasquale
    Pastori, Daniele
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (05):
  • [27] Contemporary survival and anticoagulation of patients with atrial fibrillation: A community based cohort study in China
    Wei, Yong
    Zeng, Qingye
    Cai, Lidong
    Wang, Xingjie
    Wang, Bin
    Shen, Chaoying
    Li, Chao
    Wang, Caihong
    Shen, Yahong
    Yang, Shunhong
    Wu, Xiaoyu
    Liu, Yan
    Xu, Juan
    Lu, Xiaofeng
    Chen, Songwen
    Zhou, Genqing
    Liu, Shaowen
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [28] Zhang M, 2022, AM J TRANSL RES, V14, P3269
  • [29] Atrial fibrillation in mainland China: epidemiology and current management
    Zhang, S.
    [J]. HEART, 2009, 95 (13) : 1052 - 1055